Sort
25,944 grants matching “neurodegeneration”
Mechanisms of Circadian and Synaptic Dysfunction After Repetitive Mild TBI
$2,366,184Michael J Whalen · Massachusetts General Hospital · RF1 · FY2022 · NS
Biomarkers of neurodegeneration in the US and India: A cross-national evaluation of the biological underpinnings of ADRD
$2,365,042Alden L. Gross · Johns Hopkins University · RF1 · FY2024 · AG
RNA dynamics and co-translational decay in aging and aging-related disease
$2,363,864Manolis Maragkakis · National Institute On Aging · ZIA · FY2025 · AG
Structure and Genesis of tau Aggregates
$2,363,370Jeff A Kuret · Ohio State University · RF1 · FY2017 · AG
Immunologic and Imaging studies with TNF Therapy in Prodromal Synucleinopathies
$2,361,361Jesse Cedarbaum · Yale University · R01 · FY2025 · AG
Modeling the impact of regulatory and splicing variants on cellular function in Alzheimer's disease
$2,360,820Towfique Raj · Icahn School Of Medicine At Mount Sinai · RF1 · FY2021 · AG
"What is N?" Towards operationalizing neurodegeneration in Alzheimer's and related dementias
$2,360,353Jonathan Graff-Radford · Mayo Clinic Rochester · RF1 · FY2021 · AG
Pathobiology of Neurodegeneration in C9ORF72 repeat expansion
$2,357,659Leonard Petrucelli · Mayo Clinic Jacksonville · P01 · FY2021 · NS
Single cell analysis of the kinome
$2,357,600Long Cai · California Institute Of Technology · DP1 · FY2025 · NS
Defining Endoplasmic Reticulum Stress-Development Mitochondria Remodeling
$2,356,233Rockland L Wiseman · Scripps Research Institute, The · RF1 · FY2022 · NS
Loss of VCP Function in Frontotemporal Lobar Degeneration
$2,356,099Edward Byung-Ha Lee · University Of Pennsylvania · RF1 · FY2022 · AG
Multidimensional mapping of vulnerable cell types in humanized Alzheimer's disease mouse models
$2,354,412Inma Cobos · Stanford University · R01 · FY2023 · AG
Vascular Mechanisms of Dementia: Cell-Type Specific Therapeutic and Imaging Strategies
$2,352,735Jaime Grutzendler · Yale University · RF1 · FY2022 · NS
Functional Imaging of The Brain
$2,345,733Alan Koretsky · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Immunomodulatory ligand B7-1 targets p75 neurotrophin receptor in neurodegeneration
$2,345,480Barbara L Hempstead · Weill Medical Coll Of Cornell Univ · RF1 · FY2023 · AG
Disease Model Development and Phenotyping Project
$2,345,210Gareth R Howell · Indiana University Indianapolis · U54 · FY2019 · AG
Impact of Amyloid and Tau on the Aging Brain: The Harvard Aging Brain Study
$2,345,103Reisa A. Sperling · Massachusetts General Hospital · P01 · FY2015 · AG
KBASE2: Korean Brain Aging Study, Longitudinal Endophenotypes and Systems Biology
$2,344,572Andrew J Saykin · Indiana University Indianapolis · U01 · FY2023 · AG
Pharmaceutical Research Center
$2,340,897Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2011 · RR
Pharmaceutical Research Center
$2,340,738Karam F.a. Soliman · Florida Agricultural And Mechanical Univ · G12 · FY2012 · MD
Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic development
$2,338,855Daniel C. Javitt · Nathan S. Kline Institute For Psych Res · RF1 · FY2025 · MH
Frontotemporal Dementias: Genotypes and Phenotypes
$2,337,667Virginia M Lee · University Of Pennsylvania · P01 · FY2017 · AG
Protective roles of taurine in Alzheimer's disease brain
$2,337,294Bruce Jenkins · Massachusetts General Hospital · RF1 · FY2020 · AG
Neuroplasticity and the emergence of motor and cognitive deficits in prodromal synucleinopathy
$2,336,166Colum D Mackinnon · University Of Minnesota · RF1 · FY2022 · NS
Anti-Viral therapy in Alzheimer's disease
$2,335,690Davangere P Devanand · Columbia University Health Sciences · R01 · FY2021 · AG